Where Are the Women?: The Strange Case of the Missing Feminists. When Was the Last Time You Saw One on TV?
In: The women's review of books, Volume 21, Issue 1, p. 5
11 results
Sort by:
In: The women's review of books, Volume 21, Issue 1, p. 5
In: The women's review of books, Volume 22, Issue 1, p. 17
In: Child abuse & neglect: the international journal ; official journal of the International Society for the Prevention of Child Abuse and Neglect, Volume 22, Issue 10, p. 987-995
ISSN: 1873-7757
In: The Journal of sex research, p. 1-12
ISSN: 1559-8519
In: The Journal of sex research, Volume 61, Issue 7, p. 1062-1072
ISSN: 1559-8519
In: Leisure sciences: an interdisciplinary journal, Volume 11, Issue 3, p. 201-216
ISSN: 1521-0588
In: Family relations, Volume 42, Issue 3, p. 293
ISSN: 1741-3729
In: Children and youth services review: an international multidisciplinary review of the welfare of young people, Volume 160, p. 107568
ISSN: 0190-7409
In: Risk analysis: an international journal, Volume 36, Issue 7, p. 1332-1356
ISSN: 1539-6924
Congenital rubella syndrome (CRS) continues to cause disability among unvaccinated populations in countries with no or insufficient rubella vaccine coverage to prevent transmission. We systematically reviewed the literature on birth outcomes associated with CRS to estimate the duration, severity, and frequency of combinations of morbidities. We searched PubMed, the Science Citation Index, and references from relevant articles for studies in English with primary data on the frequency of CRS manifestations for ≥20 cases and identified 65 studies representing 66 study populations that met our inclusion criteria. We abstracted available data on CRS cases with one or more hearing, heart, and/or eye defect following maternal rubella infection during the period of 0–20 weeks since the last menstrual period. We assessed the quality and weight of the available evidence using a modified Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Most of the evidence originates from studies in developed countries of cohorts of infants identified with CRS in the 1960s and 1970s, prior to the development of standardized definitions for CRS and widespread use of vaccine. We developed estimates of undiscounted disability‐adjusted life years (DALYs) lost per CRS case for countries of different income levels. The estimates ranged from approximately 19 to 39 for high‐income countries assuming optimal treatment and from approximately 29 to 39 DALYs lost per CRS case in low‐ and lower‐ middle‐income countries assuming minimal treatment, with the lower bound based on 2010 general global burden of disease disability weights and the upper bound based on 1990 age‐specific and treatment‐specific global burden of disease disability weights. Policymakers and analysts should appreciate the significant burden of disability caused by CRS as they evaluate opportunities to manage rubella.
We estimated the economic impact of concurrent measles and rubella outbreaks in Romania during 2011–2012. We collected costs from surveys of 428 case-patients and caretakers, government records, and health staff interviews. We then estimated financial and opportunity costs. During the study period, 12,427 measles cases and 24,627 rubella cases were recorded; 27 infants had congenital rubella syndrome (CRS). The cost of the outbreaks was US $9.9 million. Cost per case was US $439 for measles, US $132 for rubella, and US $44,051 for CRS. Up to 36% of households needed to borrow money to pay for illness treatment. Approximately 17% of patients continued to work while ill to pay their treatment expenses. Our key study findings were that households incurred a high economic burden compared with their incomes, the health sector bore most costs, and CRS costs were substantial and relevant to include in rubella outbreak cost studies.
BASE